BioVie
BIVI
49 hedge funds and large institutions have $3.55M invested in BioVie in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 10 closing their positions.
46% more capital invested
Capital invested by funds: $2.42M → $3.55M (+$1.12M)
23% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 13
0.07% more ownership
Funds ownership: 0.05% → 0.12% (+0.07%)
8% less funds holding
Funds holding: 53 → 49 (-4)
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
80% less call options, than puts
Call options by funds: $47K | Put options by funds: $231K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
+$3.09M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$706K |
| 3 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$615K |
| 4 |
Renaissance Technologies
New York
|
+$356K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$300K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$145K |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
-$102K |
| 3 |
Millennium Management
New York
|
-$24.5K |
| 4 |
EGM
Engineers Gate Manager
New York
|
-$24K |
| 5 |
BlackRock
New York
|
-$23.2K |
BIVI Hedge Fund Activity: Q1 2024 in Review
49 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in BioVie (BIVI) for Q1 2024, worth a combined $3.55M — up 46% from $2.42M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of BIVI and 7 opened new positions — a net loss of 3 holders — while 13 trimmed existing stakes and 16 added.
The largest buyer was Altium Capital Management, opening a new position worth an estimated $3.09M. The largest seller was Morgan Stanley, cutting an estimated $145K.
- 49 institutional investors held BioVie (BIVI) as of Q1 2024, down from 53 in Q4 2023.
- Funds reported $3.55M of BioVie stock for Q1 2024, up 46% quarter-over-quarter.
- 7 funds opened new BioVie positions in Q1 2024 and 10 closed out, a net change of -3 holders.
- The largest BioVie buyer in Q1 2024 was Altium Capital Management, an estimated $3.09M added.
- The largest BioVie seller in Q1 2024 was Morgan Stanley, an estimated $145K sold.
Based on aggregated 13F filings for Q1 2024.